Company intelligence / Profile preview
EpiBone
Jersey City, New Jersey, United Statesepibone.com ↗
- Ownership
- Private
- Employees
- ~95
- Development stage
- Other
01
Overview
EpiBone has advanced its lead osteochondral product into clinical trials following FDA approval. The company uses a patient’s own stem cells to grow anatomically precise living bone and cartilage grafts that are designed to integrate naturally with the body. Early results have enabled expansion into additional products targeting skeletal reconstruction needs.
- Therapeutic areas
- OtherRheumatology
- Modalities
- Tissue engineering (personalized bone and cartilage grafts grown from stem cells)Regenerative medicine using autologous stem cells
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on EpiBone.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EpiBone.